3-Cyclobutylpropanal | 18543-43-6

• 分子结构分类: 有机化合物 - 有机氧化合物
• 英文名称: 3-Cyclobutylpropanal
• CAS: 18543-43-6
• 化学式: C₇H₁₂O
• 分子量: 112.17
• InChiKey: OECCKISSVGVIIQ-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.7
• 重原子数：
  8
• 可旋转键数：
  3
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.86
• 拓扑面积：
  17.1
• 氢给体数：
  0
• 氢受体数：
  1

文献信息

• [EN] NOVEL COMPOUNDS, THEIR PREPARATION AND USE<br/>[FR] NOUVEAUX COMPOSES, LEUR PREPARATION ET LEUR UTILISATION
  申请人：NOVO NORDISK AS

  公开号：WO2005105725A1

  公开（公告）日：2005-11-10

  Novel compounds of the general formula (I), in which the variables are as defined in claim 1, the use of these compounds as pharmaceutical compositions, pharmaceutical compositions comprising the compounds and methods of treatment employing these compounds and compositions. The present compounds are useful in the treatment and/or prevention of conditions mediated by Peroxisome Proliferator-Activated Receptors (PPAR), in particular the PPARδ subtype, namely, type 1 diabetes, type 2 diabetes, dyslipidaemia, syndrome X (including the metabolic syndrome, i.e. impaired glucose tolerance, insulin resistance, hypertriglyceridaemia and/or obesity), cardiovascular diseases (including atherosclerosis) and hypercholesterolaemia.

  通用公式（I）的新化合物，其中变量如权利要求1中定义的那样，这些化合物作为药物组成物的用途，包含这些化合物的药物组成物以及使用这些化合物和组成物的治疗方法。这些化合物在治疗和/或预防由过氧化物酶体增殖物激活受体（PPAR）介导的疾病中有用，特别是PPARδ亚型，即1型糖尿病，2型糖尿病，血脂异常，X综合征（包括代谢综合征，即糖耐量受损，胰岛素抵抗，高三酰甘油血症和/或肥胖症），心血管疾病（包括动脉粥样硬化）和高胆固醇血症的条件。
• 1,3-Disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
  申请人：——

  公开号：US20020035103A1

  公开（公告）日：2002-03-21

  Compounds of formula I 1 are useful in treating diseases or conditions prevented by or ameliorated with histamine-3 receptor ligands. Also disclosed are histamine-3 receptor ligand compositions and methods of antagonizing or agonizing histamine-3 receptors.

  公式I1的化合物在治疗由组织胺-3受体配体防止或改善的疾病或病况中非常有用。还公开了组织胺-3受体配体组合物和拮抗或激动组织胺-3受体的方法。
• 1,3-disubstituted and 1,3,3-trisubstituted pyrrolidines as histamine-3 receptor ligands and their therapeutic applications
  申请人：——

  公开号：US20020137931A1

  公开（公告）日：2002-09-26

  Compounds of formula I 1 are useful in treating diseases or conditions prevented by or ameliorated with histamine-3 receptor ligands. Also disclosed are histamine-3 receptor ligand compositions and methods of antagonizing or agonizing histamine-3 receptors.

  公式I1的化合物在治疗由组胺-3受体配体防止或改善的疾病或症状中很有用。还披露了组胺-3受体配体组合物和拮抗或激动组胺-3受体的方法。
• Antibacterial, antifungal compound and its production method
  申请人：Takeda Chemical Industries, Ltd.

  公开号：EP0599265A1

  公开（公告）日：1994-06-01

  A compound represented by the following formula: wherein R is an acyl group which may or not be substituted. R¹ is a hydrogen atom, C₁₋₁₀ hydrocarbon group which may or may not be substituted, or an acyl group which may or may not be substituted, R² is a straight chain or branched C₁₋₁₂ alkylene group which may or may not be substituted, A is a straight chain or branched C₁₋₁₀ alkylene group, B is O, NH or S, Q is a tertiary amino or quaternary ammonium group, a nitrogen-containing heterocyclic group which may or may not be substituted, or a nitrogen-containing heterocyclic ammonium group which may or may not be substituted, and n is an integer from 1 to 10, and the method of manufacturing this compound.

  以下化合物的化学式：其中R是一个酰基，可以是取代或非取代的。R¹是氢原子，C₁₋₁₀烃基，可以是取代或非取代的酰基，R²是直链或支链的C₁₋₁₂烷基，可以是取代或非取代的，A是直链或支链的C₁₋₁₀烷基，B是O，NH或S，Q是三级胺或季铵基，一种含氮杂环基团，可以是取代或非取代的，或者一种含氮杂环铵基团，可以是取代或非取代的，n是1到10的整数。以及制造该化合物的方法。
• Histamine-3 receptor ligands for diabetic conditions
  申请人：——

  公开号：US20030153548A1

  公开（公告）日：2003-08-14

  The invention relates to a method of treating a diabetic condition by administering a therapeutically effective amount of a histamine-3 receptor antagonist, including benzofuran and benzopyran derivatives of formula (I), aminoalkoxybiphenylcarboxamide compounds of formula (III), and aminoetherbiphenyl compounds of formula (IV) as described herein.

  本发明涉及通过给予治疗有效量的组织胺-3受体拮抗剂治疗糖尿病病情的方法，包括公式(I)的苯并呋喃和苯并吡喃衍生物，公式(III)的氨基烷氧基联苯甲酰胺化合物，以及公式(IV)的氨基醚联苯化合物。